Non-replicating bacteria are known to be (or at least commonly thought to be) refractory to antibiotics to which they are genetically susceptible. Here, we explore the sensitivity to killing by bactericidal antibiotics of three classes of non-replicating populations of planktonic bacteria; (1) stationary phase, when the concentration of resources and/or nutrients are too low to allow for population growth; (2) persisters, minority subpopulations of susceptible bacteria surviving exposure to bactericidal antibiotics; (3) antibiotic-static cells, bacteria exposed to antibiotics that prevent their replication but kill them slowly if at all, the so-called bacteriostatic drugs. Using experimental populations of Staphylococcus aureus Newman and Escherichia coli K12 (MG1655) and respectively 9 and 7 different bactericidal antibiotics, we estimate the rates at which these drugs kill these different types of non-replicating bacteria. Contrary to the common belief that bacteria that are non-replicating are refractory to antibiotic-mediated killing, all three types of non-replicating populations of these Gram-positive and Gram-negative bacteria are consistently killed by aminoglycosides and the peptide antibiotics, daptomycin and colistin, respectively. This result indicates that non-replicating cells, irrespectively of why they do not replicate, have an almost identical response to bactericidal antibiotics. We discuss the implications of these results to our understanding of the mechanisms of action of antibiotics and the possibility of adding a short-course of aminoglycosides or peptide antibiotics to conventional therapy of bacterial infections.
Introduction
For therapeutic purposes, the relationship between the concentrations of antibiotics and the rates of growth and death of bacteria, pharmacodynamics, is almost exclusively studied in-vitro under conditions that are optimal for the action of these drugs; relatively low densities of bacteria growing exponentially in media and under culture conditions where all members of the exposed population have equal access to these drugs, resources, wastes and metabolites excreted into the environment. To be sure, in some sites and tissues in acutely infected hosts, relatively low densities of the target pathogens may be growing exponentially at their maximum rate and thus are under conditions that are optimal for the action of antibiotics. However, this situation is almost certainly uncommon in established, symptomatic and thereby treated infections where the offending bacteria are likely to be compartmentalized in different sites and tissues and confronting the host's immune defenses (1) .
Infecting populations of bacteria may be non-replicating for different reasons and by different mechanisms. First, they may have exhausted the locally available resources; thus modified their environment so their populations are at or near stationary phase (2) (3) (4) (5) (6) . Second, although local nutrients may be sufficient for their replication, for hosts treated with bactericidal drugs these bacteria may be minority populations of physiologically refractory survivors, the so-called "persisters" (7) (8) (9) (10) (11) (12) (13) . Third, the offending bacteria may be non-replicating because of exposure to bacteriostatic antibiotics, a state we shall refer to as antibiotic-induced stasis. Fourth, infecting bacteria may be slowly replicating or at stationary phase inside phagocytes or other host cells (14, 15) , or attached to the surfaces of tissues or prosthetic devices and within polysaccharide matrices know as biofilms (16) and thereby not replicating for one or more of previously described reasons (4, 17) .
The concept of antibiosis has been classically linked to the fight against of microbes invading host tissues and thereby implying their active replication. With some exceptions associated with permeability (18) , the susceptibility of bacteria to killing by bactericidal antibiotics is related to their rate of replication. In fact, with beta-lactams, the rate at which bacteria are killed has been shown to be strictly proportional to the rate at which the population is growing (19, 20) . The same trend seems to occur for other bactericidal agents as fluoroquinolones, aminoglycosides, glycopeptides, and lipopeptides (21) (22) (23) (24) . It is well known that exposure to bacteriostatic antibiotics markedly reduce the efficacy of beta-lactam drugs to kill bacteria (25) (26) (27) . However, save for these cases of antagonism between bacteriostatic and bactericidal drugs and the now more than a quarter of century old classical studies by R. Eng and colleagues (28) , despite the potential clinical implications, there is remarkable little information about the pharmacodynamics of antibiotics for non-replicating populations of bacteria.
In this investigation we address two fundamental questions about the pharmacodynamics of non-replicating bacteria. What antibiotics and to what extent do these drugs kill nonreplicating bacteria? With respect to their susceptibility to antibiotic-mediated killing, are bacteria in these different non-replicating states physiologically similar? To address these questions we compare the activity of antibiotics on non-replicating bacterial populations obtained by different procedures. We present the results of experiments estimating the susceptibility of various non-replicating populations of S. aureus and E. coli to killing by respectively 9 and 7 different bactericidal antibiotics. We consider three types of non-replicating states of planktonic bacteria; (i) those at stationary phase in oligotrophic culture, (ii) the non-replicating survivors of exposure to bactericidal antibiotics, persisters, and (iii) bacteria exposed to bacteriostatic antibiotics, antibioticstatic populations. Contrary to the popular conception that antibiotics are ineffective at killing bacteria that are not replicating (19, 29, 30) , albeit not the beta-lactam drugs, even at relatively low concentrations a number of existing bactericidal antibiotics can kill non-replicating bacteria of all three states. The results of our experiments indicate that the same classes of antibiotics, the aminoglycosides and the peptides, are particularly effective at killing non-replicating bacteria irrespective of the mechanism responsible for their failure to replicate. In addition to being relevant clinically, these results are interesting mechanistically; they suggest non-replicating bacteria of different types may share a common cell physiology with respect to their interactions with antibiotics.
Results
Antibiotic-mediated killing of exponentially growing bacteria: As a baseline for our consideration of the antibiotic susceptibility of non-replicating bacteria, we explore the response of exponentially growing populations S. aureus and E coli MG1655 to antibiotics. The results of these experiments are presented in Figure 1 .
For S. aureus, the aminoglycosides, gentamicin, kanamycin and tobramycin kill to the greatest extent, with reductions in viable cell density of more than 4 orders of magnitude. Daptomycin, ciprofloxacin, vancomycin, oxacillin and ampicillin are clearly bactericidal and reduce the viable cell density by 2-3 orders of magnitude. The increase in the N(24)/N(0) ratio for rifampin can be attributed to the ascent of rifampin-resistant mutants. Even at 50X MIC, tetracycline, linezolid, and erythromycin are effectively bacteriostatic. When exponentially growing cultures of E. coli are exposed to 10X MIC of gentamicin, kanamycin, tobramycin, colistin, ciprofloxacin and meropenem, the viable cell density is below that which can be detected by plating. As with S. aureus, the failure of rifampin to reduce the viable cell density can be attributed to the ascent of rifampin-resistant mutants. For E. coli exposed to ampicillin, our results suggest that the decay in the effective concentration of this drug, probably due to the chromosomal beta-lactamase effect at high initial densities can account for the failure of this bactericidal antibiotic to reduce the viable cell density of E. coli. As evidence for this, when cell-free extracts of the 24-hour ampicillin cultures are spotted onto lawns of sensitive E. coli MG1655, there is no zone of inhibition as there is when we spot the original media containing 10XMIC ampicillin. 2-Antibiotic-mediated killing of stationary phase bacteria: For the stationary phase experiments with both S. aureus and E. coli, we used cultures that had been incubated under optimal growth conditions for 48 hours. To estimate the amount of unconsumed, residual resources in these 48-hour stationary phase cultures, and thereby the capacity for additional growth, we centrifuged and filtered (0.20 microns) 48-hour cultures of these bacteria. We then added, ~10 3 cells from overnight cultures to the cell-free filtrates, and estimated the initial viable cell density after 24 hours of incubation, respectively N(0) and N (24) . The results of these experiments with four independent E. coli cultures and three independent S. aureus cultures, suggested no significant growth for E. coli, an N(24)/N(0) ratio of 0.36 ±0.22 and some growth for S. aureus an, N(24)/N(0) ratio of 10.91 ± 5.13. It should be noted however, that absence of and with limited growth in these spent media may be a reflection of the increase in pH in these media from pH7 at time 0 to pH 8.5 at 48 hours (31) At 48 hours, the viable cell densities of the stationary phase cultures were estimated (As shown in Materials & Methods). In Figure 2 , we present the results of this stationary phase experiment. In the absence of treatment (the control), there is no significant mortality between 48 and 72 hours for either S. aureus or E. coli. For S. aureus, only high concentrations of the aminoglycosides, gentamicin, kanamycin and tobramycin, and the cyclic peptide, daptomycin are effective in reducing the viable density of these 48-hours stationary phase cultures ( Figure 2A) . For E. coli, the aminoglycosides, gentamicin, tobramycin, and kanamycin are also effective for killing stationary phase cells, as is colistin. There is no evidence for the other bactericidal antibiotics tested, ciprofloxacin and rifampin killing stationary phase E. coli.
3) Antibiotic-mediated killing of E. coli hipA7 and S. aureus bactericidal persisters: Although density of exponentially growing E. coli surviving exposure to 10XMIC ampicillin in the experiment presented in Figure 1 is in excess of 10 9 , these E. coli are not persisters, but rather ampicillin sensitive cells that grew following the β-lactamasemediated reduction in the effective concentration of ampicillin. In pilot experiments, where we increased the concentration of ampicillin to 25XMIC, the viable cell density of surviving E. coli was too low to test for the susceptibility of these bacteria to killing by other antibiotics. To address this issue, we restricted our E. coli persister experiments to hipA7 (the Moyed mutant (32)) a construct that produces 10 3 -10 4 times greater numbers of persisters than wild type due to an increase in the basal level of (p)ppGpp synthesis (33) . This is illustrated in Figure 3 , where we compare the dynamics of formation and the relative densities of persisters for E. coli MG1655 and the hipA7 construct exposed to 10X MIC ampicillin.
Figure 3-Dynamics of hipA7 persister formation. Changes in viable cell density of exponentially growing E. coli MG1655 (broken lines) and a hipA7 mutant of this strain (solid lines) exposed to 10X MIC ampicillin (red) and 10X MIC ciprofloxacin (blue). All data points represent the mean and standard error of three independent measurements. Average initial cell densities were 1.23 ± 0.34 x 10 7 CFU/ml and 6.71 ± 3.16 x 10 6 CFU/ml for MG1655 and hipA7, respectively. . For S. aureus, we restricted our experiments exploring the sensitivity of persisters to treatment with bactericidal antibiotics to ampicillin-generated persisters. In our pilot experiments generating these persisters with ciprofloxacin, kanamycin and tobramycin the viable cell density of surviving cells was too low to test for the susceptibility to killing by other antibiotics. To generate these S. aureus persisters, we used a protocol similar to that employed by (34) . The results of these experiments are presented in Figure 4A . The extent to which these ampicillin-exposed S. aureus die following subsequent treatment is noted in by the N(24)/N(0) ratios of the controls, CONT. These S. aureus persisters are refractory to killing at 50XMIC concentrations of the bactericidal antibiotics ciprofloxacin, vancomycin, oxacillin and 20XMIC rifampin. This is not the case for the aminoglycosides, 5XMIC gentamicin, and 20XMIC tobramycin and kanamycin reduce the viable cell densities of these persisters by nearly three orders of magnitude. Albeit to an extent less than these aminoglycosides, at 20XMIC, the cyclic peptide daptomycin also kills these ampicillin-generated S. aureus persisters. The hipA7 persisters were prepared by exposure to ampicillin and ciprofloxacin with a protocol similar to that employed by Keren and colleagues (35) . The results of these experiments are presented in Figures 4B and 4C . Relative to the controls, low, but super-MIC concentrations of the aminoglycosides, gentamicin, kanamycin and tobramycin and also the peptide colistin reduce the viable cell density of the E. coli hipA7 persisters by three to six orders of magnitude. Even at 50XMIC the other antibiotics have little or no effect in reducing the viable cell density of the E. coli hipA7 persisters. The S. aureus antibiotic-static populations surviving exposure to tetracycline, erythromycin and linezolid are killed by the aminoglycosides, rifampin and daptomycin. The E. coli antibiotic-static populations surviving exposure to azithromycin, chloramphenicol and tetracycline are readily killed by the aminoglycosides and colistin and marginally if at all so by high concentrations of rifampin. Higher concentrations of gentamicin (10XMIC) are more effective than 10XMIC of the other aminoglycosides.
Discussion
During the course of an infection, several different conditions contribute to the nonreplicating status of initially growing populations of the infecting bacteria, triggering type I persisters, those slow growers that are generated by exposure to a stress signal (36) . Among these conditions are stationary phase resulting from a dearth of the nutrients and resources in the infected tissues, the formation of biofilms, and the immune defenses, primarily engulfment by professional and amateur phagocytic host cells. Therapy with antibiotics will also result in the production of non-replicating populations of bacteria; persisters surviving exposure to bactericidal antibiotics, and stasis induced by bacteriostatic drugs. We postulate that although they are generated in different ways, common mechanisms are responsible for the failure of these bacteria to replicate and thereby for the same classes of antibiotic to kill them. These mechanisms involve the general stringent response, a strongly regulated process governed by the alternative sigma factor RpoS (35) up-regulated by the accumulation of hyperphosphorylated guanine nucleotides, as the "alarmone" (p)ppGpp (37) (38) (39) . That regulation might in fact reflect the metabolism of persisters which is oriented toward energy production, with depleted metabolite fluxes, which perpetuates the slow growth (12, 40) .
The contribution of the stringent response to antibiotic-induced stress is not well understood. A number of observations suggest that antibiotic exposure can trigger a RpoS-stationary response and the generation of non-replicating populations. Subinhibitory concentrations of beta-lactams induce the stringent response (41, 42) . Response to stress by bacteriostatic antibiotics acting on the ribosome (as macrolides, chloramphenicol, or tetracyclines) is likely to be manifest by the reduction in protein synthesis, which might reduce the building-up of (p)ppGpp, but that might be overcompensated by reduced degradation of this nucleotide (43, 44) . Proteome analysis of erythromycin-exposed "permeable" E. coli suggests a RpoS-regulated profile (45) . In fact, sub-inhibitory concentrations of bacteriostatic antibiotics induce the stringent response, leading to beta-lactam tolerance (46) .
Cationic peptides, including polymyxins, do not elicit RpoS response, but rather increase the permeability of the cell membranes and thereby act as rapid "external killers" (47, 48) . Whether the aminoglycosides can elicit an RpoS response is unclear at this time. As is the case of other protein synthesis inhibitors, this machinery might be less effective in the presence of the antibiotic, than in the absence; the same occur with oxidative stress responses (44) . The rapid killing observed in our work (see Figure 1 ) may well be because the stringent response has no time to develop when exposed to these drugs. However, if aminoglycosides are able to induce the RpoS response, that might favor aminoglycoside transport into cells that results in membrane-damage and killing of nongrowing cells (49) .
The cellular immune response might also be responsible for generating non-replicating populations. Salmonella RpoS-dependent genes are activated into the intracellular environment of eukaryotic cells (50) . An RpoS activated system contributes to survival of E. coli and Salmonella to the phagocyte oxidase-mediated stress resistance (51, 52) and influences intracellular survival of Legionella in macrophages and in Acanthamoeba cells (53-55). Intracellular survival is also related with the overexpression of heat-shock stress proteins, promoting non-replication (56, 57) .
These studies suggest that non-replicating bacteria might also arise by the stringent response derived from professional and/or non-professional phagocytosis. Of course, aminoglycosides and peptide antibiotics do not enter in eukaryotic cells, but nonreplicating bacteria can be released from phagocytes lysed by bacteria-induced programmed necrosis, contributing to the chronification of the infection (58) . Antibodyantibiotic conjugates might improve therapy of phagocytized bacteria where aminoglycosides and peptides are excluded (15) .
We postulate that essentially the same set of cellular responses occurs in the different stress-inducing conditions that bacteria encounter during the infection process, and different classes of antibiotics are similarly effective in killing these different types of non-replicating cells. These effects probably are expressed as an hormetic (dosedependent) stress response (59, 60) . Of course, non-growth is a complex mechanism in which the final antibiotic effects are influenced by those resulting from different coexisting stresses, for instance, non-growth resulting from ribosome hibernation could facilitate some degree of gentamicin tolerance (61) . The non-growing phenotype is therefore causally complex, which negatively influences the full quantitative repeatability of the experiments.
It is well known that stationary phase populations of bacteria are refractory to killing by some antibiotics (19, 29, 30) . The results presented here illustrate that this is not the case for other antibiotics, and particularly some aminoglycosides and peptide antimicrobials kill stationary phase populations of E. coli and S. aureus. This observation is not new; it has been known for some time that the aminoglycosides and the cyclic peptides, daptomycin and colistin are capable of killing stationary phase bacteria (24, (61) (62) (63) . Less seems to be known about the susceptibility to killing by bactericidal antibiotics of the other non-replicating states of bacteria considered here, persisters and bacteria with antibiotic-induced stasis.
Although there have been many studies of persistence, relatively little is known about the susceptibility of these non-replicating bacteria to antibiotics other than those employed to generate them. One exception to this is a study by Allison and colleagues, (64) that demonstrates that by adding metabolites, E. coli and S. aureus persisters in the form of biofilms become susceptible to killing by aminoglycosides. Our results with the ampicillin-generated planktonic S. aureus persisters are fully consistent with these observations. Results with the hipA7 persisters used in this work also suggest that E. coli "natural" persisters are sensitive to killing by even low concentrations of the aminoglycosides and the peptide colistin.
There is also a relative dearth of quantitative information about the susceptibility to antibiotic-mediated killing of non-replicating bacteria induced by exposure to bacteriostatic antibiotics. To be sure, within the first decade after the discovery of antibiotic, there was evidence for exposure to bacteriostatic drugs reducing the efficacy of bactericidal (65) and these observations were corroborated more recently (27) . Early observations concerning the lower efficacy of penicillin in static cells produced by chloramphenicol and the tetracyclines have engendered what some may see as an immutable law in the practice of antibiotic therapy, do not mix bacteriostatic and bactericidal drugs. However, we show that some existing bactericidal antibiotics are quite effective in killing bacteria that are not replicating because exposure to bacteriostatic antibiotics, what we refer to as antibiotic-static populations.
In summary, stationary-phase S. aureus populations are killed at a substantial rate by the aminoglycosides and to a lesser extent by daptomycin. S. aureus persisters generated by exposure to ampicillin are also killed aminoglycosides and the lipopeptide daptomycin, but not the other drugs tested. Antibiotic-induced static populations of S. aureus maintain the same killing profile, with aminoglycosides and daptomycin as the sole killing agents, with the exception, in this case of rifampicin. Some aminoglycosides and the peptide colistin are also effective at killing stationary phase E. coli, whilst the other antibiotics tested were not. This is also the case for the hipA7 E. coli persister and E. coli "suffering" from the stasis induced by ribosome-targeting bacteriostatic antibiotics. This homogeneous pattern of response to antibiotic killing in differently originated slowgrowth populations support a basically homogeneous physiology in all type I persisters.
Potential clinical implications
In recent years there has been a great deal of interest in discovering and developing drugs to treat non-replicating populations of bacteria, particularly those associated with biofilms. A prime example of this is Kim Lewis and colleague's (66) use of a novel antibiotic, acyldepsipeptide (ADEP4). Despite growing efforts in the endeavor to find new antibiotics to kill non-replicating bacteria, the results presented here suggest that existing antimicrobials may well be up to that task. A well-warranted concern is that the antibiotics with this virtue are among the more toxic drugs, aminoglycosides and the peptides (67) (68) (69) . It should be noted, however, relatively low, and possible non-toxic concentrations of the aminoglycosides and the peptide, colistin can kill E. coli antibioticstatic and hipA7 persisters. Most importantly, as has been the case with cancer chemotherapy, there are conditions under which some toxic side-effects of systemic treatment are more then made up for by the sometimes life-saving benefits of that treatment (70) . Of course, inhaled therapy, providing very high local concentrations of aminoglycosides or peptidic antibiotics, has proven its efficacy in mostly non-growing populations of Pseudomonas aeruginosa and Staphylococcus aureus involved in chronic lung colonization in cystic fibrosis patients (71) . Also, high local concentrations of these antibiotics have been useful in intravesical therapy of recurrent urinary tract infections (72) or in catheter locking solutions to treat catheter-related bloodstream infections (73) .
How important persisters are clinically is, at this juncture, not all that clear. Persisters remain susceptible to phagocytosis and other elements of the innate immune system, the main factor influencing control of infections, can be attributed to the innate immune system, and they would play little or no role in reducing the efficacy of antibiotic therapy (74) . Consistent with this yet-to-be tested (but testable) hypothesis in experimental animals and patients is the observation that for immune competent patients, bacteriostatic drugs are as effective for treatment as highly bactericidal agents (75, 76) .
As intriguing as they may be scientifically, planktonic persisters surviving exposure to bactericidal antibiotics are not the majority of the non-replicating bacteria present during the infection process. Stationary phase bacteria resulting from local shortage of nutrients, non-growing populations induced by bacteriostatic agents, biofilm populations and phagocytosed bacteria (eventually released by the lysis of the engulfing phagocytes) are likely to be the majority of phenotypically antibiotic resistant bacteria in an established infection. They are certainly involved in chronification of infections, and subsequent reactivations and relapses. It may well be that along with the standard therapy, the addition of a short-course administration of antibiotics that kill these nonreplicating bacteria, like the aminoglycosides and peptides, may well accelerate the course of treatment and increase the likelihood of its success. coli MG1655 the MICs of the antibiotic were estimated using the two-fold micro dilution procedure (77) . Two different initial concentrations of antibiotics were used to obtain accurate measurements from the two-fold micro dilution procedure. The estimated MICs of each of the antibiotic bacteria combination are listed in Table 1 . Table 1 Minimum Inhibitory Concentrations in µg/ml. N(24)/N(0) Ratios: As our measure of the efficacy of the different antibiotics to killing the exposed bacteria, we use the ratio of the viable cell density after 24 hours of exposure to the drug and the initial density estimated prior to exposure, N(24)/N(0). For each experiment, we estimated the N(0) and N(24) densities (CFUs) with three independent serial dilutions. For each antibiotic -bacteria combination, unless otherwise stated, we ran at least three independent experiments and calculated the mean and standard error of the N(24)/N(0) ratios.
Materials & Methods

Bacteria: Staphylococcus aureus
Antibiotic-mediated killing of exponentially growing bacteria: For these experiments, overnight cultures of S. aureus and E. coli MG1655 were added to broth at a ratio of 1:100 and incubated for 1.5 hours and the density of the cultures estimated, N(0). Five mls of these cultures were then put into 6-well plates and the antibiotics added. The cultures with the antibiotics were incubated for 24 hours at which time the viable cell densities were estimated, N(24).
Antibiotics-mediated killing of stationary phase bacteria: For the stationary phase experiments with both S. aureus and E. coli, we used cultures that had been incubated under optimal growth conditions for 48 hours. At 48 hours, the viable cell densities of the stationary phase cultures were estimated, N(0). Following that, five ml aliquots were put into 6-well plates, the antibiotics added, and the cultures incubated with shaking for another 24 hours, at which time the viable cell densities were estimated.
Antibiotic-mediated killing of S. aureus bactericidal persisters: Overnight MHII cultures of S. aureus Newman were diluted 1/10 in fresh MHII and 25XMIC ampicillin added immediately.
After 24 hours, the viable cell densities were estimated, N(0). Five mls of these ampicillin treated cultures were put into 6-well plates and the second antibiotic(s) added and the cultures incubated with shaking for another 24 hours.
Antibiotic-mediated killing of E. coli hipA7 bactericidal persisters: Exponentially growing LB cultures of E. coli hipA7 were exposed to 10X MIC ciprofloxacin or ampicillin for 4 hours, N(0) at which time they were treated with the second antibiotic for another 24 hours, N(24).
Antibiotic-mediated killing of antibiotic-induced static populations: Antibioticinduced static populations were generated by exposing exponentially growing S. aureus and E. coli to bacteriostatic drugs for 24 hours, at which time the viable cell density was estimated N(0). The culture was divided into five ml aliquots in 6-well plates and the second antibiotic added. The cultures were maintained for another 24 hours and the viable cell densities estimated, N(24).
A Caveat: As quantitative biologists, we found our experiments with antibioticmediated killing and persisters to be somewhat frustrating. The magnitude of the variation in the extent of antibiotic-mediated killing and levels of persistence among independent replicas was often substantial. We did a great deal of replication and are confident about the results reported here, in a semi-quantitative way. By the latter, we mean that we are convinced that the relative extents of kill and levels of persistence by the antibiotics used here would be obtained in parallel experiments in other laboratories. On the other hand, we would be surprised if the absolute numbers of bacteria surviving exposure to these drugs in these experiments would be identical to those reported here.
Curiously, when we discuss experimental studies of persistence and related topics with colleagues working on these subjects, they too whine about the variation among experiments, but this variation is rarely reported, for an exception see (78) . Contributing to this variation is, of course, differences among batches of media, and particularly broths. Moreover and perhaps more important is variation in the strains used by different laboratories and possibly even by the same laboratory at different times. Although designated, E. coli MG1655 or S. aureus Newman, every time those bacteria are re-cloned, there is a possibility of the random fixation mutations, which in the course of time can affect the phenotype of the cell line including declines in fitness, a phenomenon called Muller's Ratchet (79) . This accumulation of mutations can be seen as DNA sequence data as well as phenotypic variation among isolates of strains with the same name, see for example (80, 81) . In addition, it seems clear that persistence and the response of bacteria to antibiotics are multi-causal phenotypes; as is the rule in complex systems, the quantitative reproducibility of experiments is frequently impaired, as small and difficult-to-control variations in the initial variables can quantitatively influence the final result (82) 
